Table 2. Correlation between clinicopathologic factors and expression of nuclear survivin in breast cancer.
Nuclear survivin expression |
|||
---|---|---|---|
Negativea (n=154) | Positiveb (n=139) | P-value | |
Age (years) | |||
⩽60 | 93 | 89 | n.s. |
>60 | 61 | 50 | |
Histological grade | |||
I+II | 75 | 79 | n.s. |
III | 79 | 60 | |
Lymph node status | |||
Node − | 76 | 88 | n.s. |
Node + | 78 | 51 | |
ER status | |||
+ (⩾10 fm mg−1) | 96 | 99 | n.s. |
− (<10 fm mg−1) | 51 | 35 | |
Unknown | 7 | 5 | |
Tumour size (cm) | |||
⩽2.8 | 77 | 71 | n.s. |
>2.8 | 77 | 68 | |
Adjuvant chemotherapy | |||
Yes | 76 | 70 | n.s. |
No | 68 | 64 | |
Unknown | 10 | 5 | |
Tamoxifen | |||
Yes | 91 | 73 | n.s. |
No | 51 | 60 | |
Unknown | 12 | 6 |
⩽20% nuclear survivin expression.
>20% nuclear survivin expression. n.s.=not significant.